Fintech firm Finvasia has crossed five million client base in over 190 countries and have transacted trillions of dollar worth in value through its 10-plus brands combined.
Mumbai-headquartered Finvasia, a multinational organisation, owns and operates over a dozen brands across financial services, technology, real estate and healthcare verticals.
Founded in 2009 by Sarvjeet and Tajinder Virk, Finvasia has blended financial services, healthcare, biomedical engineering, and investment banking.
The company’s first major disruption came in the Indian financial markets with the launch of Shoonya, the country’s first truly zero-commission trading platform. The market responded with millions of traders joining the platform, compelling even the most established brokerage houses to reconsider their pricing structures.
In 2021, Finvasia acquired ZuluTrade, a leading social trading platform that had already facilitated over $2 trillion in trades across over 150 countries.
- Also read: Retail inflation is expected to settle at 4.1% in Feb’ 25: BoB Economic Research
AI-driven analytics, risk management features and a more collaborative investment environment turned ZuluTrade into a hub where traders, investors and brokers could leverage data-driven insights to make informed decisions.
The company then entered Jumpp, an AI-powered neo-banking super app. Built in collaboration with YES Bank, Jumpp empowers users with real-time spending insights, AI-driven budgeting recommendations, and multilingual support.
Ethniq was one of Finvasia’s pioneering ventures. It developed plant-based, scientifically validated medicines aimed at prevention rather than just treatment. With ten products already approved by FSSAI and AYUSH India, and more awaiting patents.
ActTrader, a professional-grade trading platform, became a cornerstone of Finvasia’s ecosystem, ensuring seamless execution for high-frequency traders and institutional investors.
With Bodyloop, Finvasia ventured into real-time, in-body microsensor technology—an initiative that could redefine how health is monitored. It offers continuous and seamless tracking of vital parameters.
Gini Health is a DNA-based healthcare facility focused on reversing diabetes. Instead of merely managing the disease, Finvasia applied AI-driven diagnostics and genomics to create personalised treatment plans designed to combat diabetes at its root.
Finvasia brokerage and investment banking operations spanned Mauritius, the UAE, South Africa, and the European Union, offering structured finance solutions and strategic advisory services to a diverse clientele.
